HemoSense to Present at the Friedman Billings Ramsey Growth Conference

  
    
  
  
    
      HemoSense, Inc. (AMEX:HEM) today announced that Jim Merselis, 
      President and CEO, will make an investment community presentation at the 
      2007 FBR Growth Conference on Thursday, May 31, at 2:20 p.m. Eastern 
      time (11:20 a.m. Pacific time). The conference is being held at the 
      Grand Hyatt Hotel in New York City.
    
    
      A live audio and slide webcast of the presentation will be available via 
      the Internet by visiting the Investors section of the Company’s 
      Web site at www.hemosense.com. An 
      archived presentation will be available on the Web site for 30 days.
    
    
      About HemoSense
    
    
      HemoSense is a point-of-care diagnostic healthcare company that 
      develops, manufactures and markets easy-to-use, handheld blood 
      coagulation systems for monitoring patients taking warfarin. The 
      HemoSense INRatio® system, used by healthcare 
      professionals and patients themselves, consists of a small monitor and 
      disposable test strips. It provides accurate and convenient measurement 
      of blood clotting time, or PT/INR values. Routine measurements of PT/INR 
      are necessary for the safe and effective management of the patient’s 
      warfarin dosing. INRatio is sold in the United States and 
      internationally. For more information, visit www.hemosense.com.
    
    
      HemoSense® and INRatio® 
      are registered trademarks of HemoSense, Inc.